ANI Pharma (ANIP) Reports Q3 Loss of $0.37/sh

ANI Pharma (NASDAQ: ANIP) reported Q3 EPS of ($0.37), versus $0.04 reported last year. Revenue for the quarter came in at $52.1 million, versus $52.98 million reported last year.

For earnings history and earnings-related data on ANI Pharma (ANIP) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Arrive AI and DXC Technology partner to bring delivery tech to factories
• Barclays says AI trade is maturing, favors greater diversification